Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasha Qiu

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Chemical Reviews|September 15, 2023
Tumor Abnormality-Oriented Nanomedicine DesignQuan Zhou, Jiajia Xiang, Nasha Qiu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 4, 2020
Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancerYun Liu, Nasha Qiu, Limei Shen, et al.
Advanced Drug Delivery Reviews|August 6, 2017
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integrationZhuxian Zhou, Xiangrui Liu, Dingcheng Zhu, et al.
Nanoscale Horizons|February 15, 2021
Tumor-targeted gene therapy with lipid nanoparticles inhibits tumor-associated adipocytes and remodels the immunosuppressive tumor microenvironment in triple-negative breast cancerYun Liu, Karthik Tiruthani, Menglin Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 28, 2016
Esterase-Activated Charge-Reversal Polymer for Fibroblast-Exempt Cancer Gene TherapyNasha Qiu, Xiangrui Liu, Yin Zhong, et al.
Biomaterials|September 10, 2021
Corrigendum to "Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy" [Biomaterials 269 (2021) 120604]Nasha Qiu, Yun Liu, Qi Liu, et al.
Biomaterials|December 31, 2020
Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapyNasha Qiu, Yun Liu, Qi Liu, et al.
Nature Communications|April 24, 2021
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapyJing Liu, Zhihao Zhao, Nasha Qiu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 24, 2016
Jumping the nuclear envelop barrier: Improving polyplex-mediated gene transfection efficiency by a selective CDK1 inhibitor RO-3306Xuefei Zhou, Xiangrui Liu, Bingxiang Zhao, et al.
Pharmaceutics|February 24, 2024
An Esterase-Responsive SLC7A11 shRNA Delivery System Induced Ferroptosis and Suppressed Hepatocellular Carcinoma ProgressionHui Zhang, Jianguo Wang, Xiaonan Xiang, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Chemical Reviews|September 15, 2023
Tumor Abnormality-Oriented Nanomedicine DesignQuan Zhou, Jiajia Xiang, Nasha Qiu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 4, 2020
Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancerYun Liu, Nasha Qiu, Limei Shen, et al.
Advanced Drug Delivery Reviews|August 6, 2017
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integrationZhuxian Zhou, Xiangrui Liu, Dingcheng Zhu, et al.
Nanoscale Horizons|February 15, 2021
Tumor-targeted gene therapy with lipid nanoparticles inhibits tumor-associated adipocytes and remodels the immunosuppressive tumor microenvironment in triple-negative breast cancerYun Liu, Karthik Tiruthani, Menglin Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|October 28, 2016
Esterase-Activated Charge-Reversal Polymer for Fibroblast-Exempt Cancer Gene TherapyNasha Qiu, Xiangrui Liu, Yin Zhong, et al.
Biomaterials|September 10, 2021
Corrigendum to "Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy" [Biomaterials 269 (2021) 120604]Nasha Qiu, Yun Liu, Qi Liu, et al.
Biomaterials|December 31, 2020
Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapyNasha Qiu, Yun Liu, Qi Liu, et al.
Nature Communications|April 24, 2021
Co-delivery of IOX1 and doxorubicin for antibody-independent cancer chemo-immunotherapyJing Liu, Zhihao Zhao, Nasha Qiu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 24, 2016
Jumping the nuclear envelop barrier: Improving polyplex-mediated gene transfection efficiency by a selective CDK1 inhibitor RO-3306Xuefei Zhou, Xiangrui Liu, Bingxiang Zhao, et al.
Pharmaceutics|February 24, 2024
An Esterase-Responsive SLC7A11 shRNA Delivery System Induced Ferroptosis and Suppressed Hepatocellular Carcinoma ProgressionHui Zhang, Jianguo Wang, Xiaonan Xiang, et al.
Pageof 4